Share Price and Basic Stock Data
Last Updated: November 6, 2025, 10:03 pm
| PEG Ratio | -11.24 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Relaxo Footwears Ltd operates in the footwear industry, reported a market capitalization of ₹10,815 Cr, with its share price standing at ₹434. The company recorded sales of ₹2,783 Cr for the fiscal year ending March 2023, reflecting a steady upward trend from ₹2,653 Cr in the previous year. The sales trajectory has shown resilience, with quarterly sales figures peaking at ₹765 Cr in March 2023 and maintaining robust levels, such as ₹739 Cr in June 2023 and ₹715 Cr in September 2023. This growth is indicative of a strong brand presence in the competitive footwear market, supported by effective marketing strategies and a diverse product range. However, the trailing twelve months (TTM) revenue stood at ₹2,696 Cr, highlighting a slight decline compared to the previous fiscal year. The company’s ability to sustain sales momentum amidst fluctuations will be vital in navigating market challenges.
Profitability and Efficiency Metrics
Relaxo’s profitability metrics reveal a mixed performance, with a net profit of ₹175 Cr reported for the fiscal year ending March 2023, down from ₹233 Cr the previous year. The operating profit margin (OPM) stood at 12% for the same period, a decline from 16% in March 2022, indicating pressures on profitability amid rising costs. In the latest quarterly results, OPM was reported at 15% in June 2023, suggesting an improvement in operational efficiency. The company’s return on equity (ROE) was recorded at 8.31%, while the return on capital employed (ROCE) was reported at 11.2%, both of which are below industry averages, pointing to potential inefficiencies in capital utilization. Furthermore, Relaxo’s interest coverage ratio (ICR) of 19.79x illustrates a strong ability to cover interest expenses, reflecting prudent financial management.
Balance Sheet Strength and Financial Ratios
Relaxo Footwears maintains a robust balance sheet, with total reserves reported at ₹2,073 Cr and borrowings of ₹213 Cr, reflecting a low debt-to-equity ratio of 0.00, indicating minimal reliance on external financing. The company’s current ratio stood at 2.74, well above the industry norm, suggesting strong liquidity and the ability to meet short-term obligations. The price-to-book value (P/BV) ratio was recorded at 4.83x, indicating a premium valuation compared to typical sector averages. Despite the strong reserves, the declining net profit and profitability margins raise concerns about future earnings growth. The company’s cash conversion cycle (CCC) of 155 days is relatively long, suggesting potential inefficiencies in inventory and receivables management, which could impact cash flow.
Shareholding Pattern and Investor Confidence
As of March 2025, Relaxo Footwears exhibits a stable shareholding pattern with promoters holding 71.27% of the equity, reflecting strong management control. The foreign institutional investors (FIIs) have a stake of 3.03%, while domestic institutional investors (DIIs) hold 9.88%. The public shareholding stood at 15.82%, indicating a diversified ownership base. However, the number of shareholders has declined from 3,61,927 in December 2022 to 2,39,270 in March 2025, signaling potential concerns regarding investor sentiment and market confidence. The dividend payout ratio has increased to 43.84%, highlighting a commitment to returning value to shareholders, which could enhance investor appeal amidst profitability challenges. The stable promoter holding and increasing dividend payout may suggest a long-term commitment to shareholder interests.
Outlook, Risks, and Final Insight
Looking ahead, Relaxo Footwears faces a dual landscape of opportunities and challenges. The company’s strong brand equity and market position provide a solid foundation for growth, but it must address declining profitability and efficiency metrics to sustain its competitive edge. Risks include rising raw material costs, which could further pressure margins, and the potential for market volatility affecting consumer spending. Additionally, the long cash conversion cycle suggests operational inefficiencies that need to be addressed. The company’s ability to innovate and adapt to market trends will be crucial in maintaining its growth trajectory. In a scenario where operational efficiencies improve, profitability could rebound, enhancing shareholder value. Conversely, persistent margin pressures could lead to further declines in profitability, necessitating strategic adjustments to ensure long-term sustainability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Relaxo Footwears Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Campus Activewear Ltd | 8,302 Cr. | 271 | 338/210 | 70.4 | 24.8 | 0.37 % | 20.1 % | 17.2 % | 5.00 |
| AKI India Ltd | 81.7 Cr. | 8.08 | 20.9/6.63 | 61.4 | 7.33 | 0.00 % | 4.54 % | 1.80 % | 2.00 |
| Relaxo Footwears Ltd | 10,896 Cr. | 437 | 782/375 | 62.3 | 84.3 | 0.69 % | 11.2 % | 8.31 % | 1.00 |
| Liberty Shoes Ltd | 527 Cr. | 308 | 568/276 | 39.5 | 134 | 0.00 % | 9.99 % | 7.20 % | 10.0 |
| Khadim India Ltd | 437 Cr. | 238 | 349/210 | 29.0 | 137 | 0.00 % | 9.34 % | 2.20 % | 10.0 |
| Industry Average | 6,730.40 Cr | 385.51 | 55.85 | 84.41 | 0.48% | 11.71% | 8.72% | 5.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 667 | 670 | 681 | 765 | 739 | 715 | 713 | 747 | 748 | 679 | 667 | 695 | 654 |
| Expenses | 581 | 610 | 609 | 647 | 631 | 624 | 626 | 627 | 649 | 592 | 584 | 583 | 555 |
| Operating Profit | 86 | 59 | 72 | 118 | 108 | 92 | 87 | 120 | 99 | 88 | 83 | 112 | 99 |
| OPM % | 13% | 9% | 11% | 15% | 15% | 13% | 12% | 16% | 13% | 13% | 12% | 16% | 15% |
| Other Income | 4 | 6 | 4 | 4 | 7 | 11 | 6 | 5 | 5 | 7 | 7 | 8 | 11 |
| Interest | 7 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Depreciation | 30 | 31 | 32 | 33 | 35 | 37 | 38 | 38 | 39 | 40 | 40 | 39 | 40 |
| Profit before tax | 54 | 30 | 41 | 85 | 76 | 60 | 51 | 82 | 60 | 50 | 45 | 75 | 66 |
| Tax % | 28% | 26% | 26% | 26% | 26% | 27% | 24% | 25% | 26% | 26% | 26% | 25% | 26% |
| Net Profit | 39 | 22 | 30 | 63 | 56 | 44 | 39 | 61 | 44 | 37 | 33 | 56 | 49 |
| EPS in Rs | 1.55 | 0.90 | 1.21 | 2.54 | 2.26 | 1.78 | 1.55 | 2.47 | 1.78 | 1.48 | 1.33 | 2.26 | 1.96 |
Last Updated: August 1, 2025, 1:20 pm
Below is a detailed analysis of the quarterly data for Relaxo Footwears Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 654.00 Cr.. The value appears to be declining and may need further review. It has decreased from 695.00 Cr. (Mar 2025) to 654.00 Cr., marking a decrease of 41.00 Cr..
- For Expenses, as of Jun 2025, the value is 555.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 583.00 Cr. (Mar 2025) to 555.00 Cr., marking a decrease of 28.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 99.00 Cr.. The value appears to be declining and may need further review. It has decreased from 112.00 Cr. (Mar 2025) to 99.00 Cr., marking a decrease of 13.00 Cr..
- For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 15.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Depreciation, as of Jun 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 39.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Mar 2025) to 66.00 Cr., marking a decrease of 9.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 49.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2025) to 49.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.96. The value appears to be declining and may need further review. It has decreased from 2.26 (Mar 2025) to 1.96, marking a decrease of 0.30.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:11 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,180 | 1,441 | 1,668 | 1,631 | 1,941 | 2,292 | 2,410 | 2,359 | 2,653 | 2,783 | 2,914 | 2,790 | 2,696 |
| Expenses | 1,032 | 1,240 | 1,427 | 1,400 | 1,639 | 1,964 | 1,998 | 1,861 | 2,235 | 2,442 | 2,505 | 2,405 | 2,313 |
| Operating Profit | 148 | 201 | 241 | 231 | 302 | 328 | 413 | 498 | 418 | 341 | 409 | 385 | 383 |
| OPM % | 13% | 14% | 14% | 14% | 16% | 14% | 17% | 21% | 16% | 12% | 14% | 14% | 14% |
| Other Income | 2 | 0 | 7 | 14 | 4 | 12 | 8 | 22 | 23 | 16 | 29 | 27 | 33 |
| Interest | 23 | 18 | 23 | 15 | 9 | 9 | 19 | 19 | 17 | 22 | 21 | 24 | 21 |
| Depreciation | 31 | 40 | 47 | 51 | 54 | 62 | 109 | 110 | 114 | 125 | 147 | 158 | 159 |
| Profit before tax | 96 | 143 | 178 | 178 | 244 | 268 | 292 | 391 | 311 | 210 | 269 | 230 | 235 |
| Tax % | 31% | 28% | 32% | 33% | 34% | 35% | 22% | 25% | 25% | 26% | 26% | 26% | |
| Net Profit | 66 | 103 | 120 | 120 | 161 | 175 | 226 | 292 | 233 | 154 | 200 | 170 | 175 |
| EPS in Rs | 2.74 | 4.29 | 5.01 | 4.99 | 6.69 | 7.07 | 9.11 | 11.74 | 9.35 | 6.21 | 8.05 | 6.84 | 7.03 |
| Dividend Payout % | 5% | 6% | 6% | 10% | 11% | 13% | 14% | 21% | 27% | 40% | 37% | 44% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 56.06% | 16.50% | 0.00% | 34.17% | 8.70% | 29.14% | 29.20% | -20.21% | -33.91% | 29.87% | -15.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -39.56% | -16.50% | 34.17% | -25.47% | 20.45% | 0.06% | -49.41% | -13.70% | 63.78% | -44.87% |
Relaxo Footwears Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -6% |
| 3 Years: | -10% |
| TTM: | -7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -5% |
| 3 Years: | -21% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 12% |
| 3 Years: | 9% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:05 pm
Balance Sheet
Last Updated: August 11, 2025, 2:39 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 12 | 12 | 12 | 12 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 271 | 362 | 468 | 594 | 749 | 1,093 | 1,248 | 1,548 | 1,735 | 1,830 | 1,976 | 2,073 |
| Borrowings | 198 | 239 | 236 | 178 | 153 | 112 | 139 | 144 | 174 | 164 | 205 | 213 |
| Other Liabilities | 182 | 234 | 281 | 286 | 335 | 394 | 430 | 459 | 448 | 476 | 508 | 452 |
| Total Liabilities | 657 | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,176 | 2,383 | 2,495 | 2,714 | 2,762 |
| Fixed Assets | 366 | 472 | 531 | 541 | 525 | 848 | 981 | 938 | 987 | 1,150 | 1,371 | 1,344 |
| CWIP | 24 | 2 | 28 | 62 | 138 | 11 | 46 | 118 | 149 | 89 | 33 | 54 |
| Investments | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 338 | 194 | 225 | 108 | 343 |
| Other Assets | 267 | 367 | 438 | 466 | 587 | 752 | 814 | 782 | 1,052 | 1,030 | 1,202 | 1,021 |
| Total Assets | 657 | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,176 | 2,383 | 2,495 | 2,714 | 2,762 |
Below is a detailed analysis of the balance sheet data for Relaxo Footwears Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,073.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,976.00 Cr. (Mar 2024) to 2,073.00 Cr., marking an increase of 97.00 Cr..
- For Borrowings, as of Mar 2025, the value is 213.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 205.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 8.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 452.00 Cr.. The value appears to be improving (decreasing). It has decreased from 508.00 Cr. (Mar 2024) to 452.00 Cr., marking a decrease of 56.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 2,762.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,714.00 Cr. (Mar 2024) to 2,762.00 Cr., marking an increase of 48.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,344.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,371.00 Cr. (Mar 2024) to 1,344.00 Cr., marking a decrease of 27.00 Cr..
- For CWIP, as of Mar 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Mar 2024) to 54.00 Cr., marking an increase of 21.00 Cr..
- For Investments, as of Mar 2025, the value is 343.00 Cr.. The value appears strong and on an upward trend. It has increased from 108.00 Cr. (Mar 2024) to 343.00 Cr., marking an increase of 235.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,021.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,202.00 Cr. (Mar 2024) to 1,021.00 Cr., marking a decrease of 181.00 Cr..
- For Total Assets, as of Mar 2025, the value is 2,762.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,714.00 Cr. (Mar 2024) to 2,762.00 Cr., marking an increase of 48.00 Cr..
Notably, the Reserves (2,073.00 Cr.) exceed the Borrowings (213.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -50.00 | -38.00 | 5.00 | 53.00 | 149.00 | 216.00 | 274.00 | 354.00 | 244.00 | 177.00 | 204.00 | 172.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21 | 21 | 24 | 28 | 33 | 35 | 26 | 28 | 34 | 35 | 45 | 41 |
| Inventory Days | 109 | 163 | 147 | 146 | 130 | 130 | 157 | 154 | 202 | 154 | 179 | 177 |
| Days Payable | 39 | 61 | 63 | 63 | 72 | 58 | 65 | 81 | 67 | 69 | 76 | 63 |
| Cash Conversion Cycle | 91 | 123 | 108 | 110 | 90 | 107 | 119 | 101 | 170 | 121 | 148 | 155 |
| Working Capital Days | 5 | 14 | 12 | 19 | 27 | 42 | 57 | 44 | 75 | 59 | 68 | 62 |
| ROCE % | 26% | 30% | 30% | 26% | 30% | 26% | 24% | 26% | 18% | 12% | 14% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Focused Equity Fund | 8,604,916 | 2.03 | 711.88 | 8,604,916 | 2025-04-22 15:17:20 | 0% |
| SBI Equity Hybrid Fund | 2,533,988 | 0.29 | 209.64 | 2,533,988 | 2025-04-22 15:16:47 | 0% |
| SBI Magnum Midcap Fund | 2,500,000 | 1.02 | 206.83 | 2,500,000 | 2025-04-22 15:56:54 | 0% |
| SBI Small Cap Fund | 1,800,000 | 0.48 | 148.91 | 1,800,000 | 2025-04-22 14:12:24 | 0% |
| SBI Multicap Fund | 1,621,704 | 0.79 | 134.16 | 1,621,704 | 2025-04-22 15:56:54 | 0% |
| SBI Large & Midcap Fund | 1,550,000 | 0.5 | 128.23 | 1,550,000 | 2025-04-22 15:56:54 | 0% |
| UTI Flexi Cap Fund | 1,526,688 | 0.49 | 126.3 | 1,526,688 | 2025-04-22 15:56:54 | 0% |
| SBI Flexi Cap Fund | 1,347,099 | 0.51 | 111.45 | 1,347,099 | 2025-04-22 15:56:54 | 0% |
| SBI Magnum Childrens Benefit Fund - Investment Plan | 400,000 | 1.42 | 33.09 | 400,000 | 2025-04-22 15:56:54 | 0% |
| Sundaram Large and Mid Cap Fund | 348,399 | 0.42 | 28.82 | 348,399 | 2025-04-22 15:56:54 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 6.84 | 8.05 | 6.21 | 9.36 | 11.74 |
| Diluted EPS (Rs.) | 6.84 | 8.05 | 6.21 | 9.35 | 11.74 |
| Cash EPS (Rs.) | 13.21 | 13.98 | 11.23 | 13.91 | 16.17 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 84.29 | 80.40 | 74.53 | 70.72 | 63.30 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 84.29 | 80.40 | 74.53 | 70.72 | 63.30 |
| Dividend / Share (Rs.) | 3.00 | 3.00 | 2.50 | 2.50 | 2.50 |
| Revenue From Operations / Share (Rs.) | 112.08 | 117.08 | 111.80 | 106.60 | 94.97 |
| PBDIT / Share (Rs.) | 16.43 | 17.49 | 14.24 | 17.66 | 20.86 |
| PBIT / Share (Rs.) | 10.07 | 11.57 | 9.21 | 13.09 | 16.43 |
| PBT / Share (Rs.) | 9.24 | 10.82 | 8.44 | 12.48 | 15.75 |
| Net Profit / Share (Rs.) | 6.84 | 8.05 | 6.21 | 9.35 | 11.74 |
| PBDIT Margin (%) | 14.66 | 14.94 | 12.73 | 16.56 | 21.96 |
| PBIT Margin (%) | 8.98 | 9.88 | 8.23 | 12.28 | 17.30 |
| PBT Margin (%) | 8.24 | 9.24 | 7.54 | 11.70 | 16.58 |
| Net Profit Margin (%) | 6.10 | 6.87 | 5.55 | 8.76 | 12.35 |
| Return on Networth / Equity (%) | 8.11 | 10.01 | 8.32 | 13.21 | 18.54 |
| Return on Capital Employeed (%) | 10.83 | 13.12 | 11.32 | 16.96 | 23.64 |
| Return On Assets (%) | 6.16 | 7.38 | 6.19 | 9.76 | 13.40 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| Asset Turnover Ratio (%) | 1.02 | 1.12 | 1.14 | 1.16 | 1.17 |
| Current Ratio (X) | 2.74 | 2.40 | 2.54 | 2.57 | 2.40 |
| Quick Ratio (X) | 1.50 | 1.25 | 1.34 | 1.11 | 1.46 |
| Inventory Turnover Ratio (X) | 4.82 | 1.99 | 1.91 | 2.39 | 1.99 |
| Dividend Payout Ratio (NP) (%) | 43.84 | 31.04 | 40.28 | 26.69 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 22.71 | 17.88 | 22.25 | 17.93 | 0.00 |
| Earning Retention Ratio (%) | 56.16 | 68.96 | 59.72 | 73.31 | 0.00 |
| Cash Earning Retention Ratio (%) | 77.29 | 82.12 | 77.75 | 82.07 | 0.00 |
| Interest Coverage Ratio (X) | 19.79 | 23.30 | 18.42 | 28.67 | 30.34 |
| Interest Coverage Ratio (Post Tax) (X) | 9.24 | 11.73 | 9.03 | 16.18 | 18.07 |
| Enterprise Value (Cr.) | 10084.44 | 20231.08 | 21055.11 | 26520.33 | 21706.20 |
| EV / Net Operating Revenue (X) | 3.61 | 6.94 | 7.57 | 10.00 | 9.20 |
| EV / EBITDA (X) | 24.66 | 46.46 | 59.42 | 60.35 | 41.88 |
| MarketCap / Net Operating Revenue (X) | 3.63 | 6.97 | 7.59 | 9.99 | 9.20 |
| Retention Ratios (%) | 56.15 | 68.95 | 59.71 | 73.30 | 0.00 |
| Price / BV (X) | 4.83 | 10.15 | 11.39 | 15.06 | 13.81 |
| Price / Net Operating Revenue (X) | 3.63 | 6.97 | 7.59 | 9.99 | 9.20 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Relaxo Footwears Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 13.21. This value is within the healthy range. It has decreased from 13.98 (Mar 24) to 13.21, marking a decrease of 0.77.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
- For Dividend / Share (Rs.), as of Mar 25, the value is 3.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 3.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 112.08. It has decreased from 117.08 (Mar 24) to 112.08, marking a decrease of 5.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.43. This value is within the healthy range. It has decreased from 17.49 (Mar 24) to 16.43, marking a decrease of 1.06.
- For PBIT / Share (Rs.), as of Mar 25, the value is 10.07. This value is within the healthy range. It has decreased from 11.57 (Mar 24) to 10.07, marking a decrease of 1.50.
- For PBT / Share (Rs.), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.24, marking a decrease of 1.58.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For PBDIT Margin (%), as of Mar 25, the value is 14.66. This value is within the healthy range. It has decreased from 14.94 (Mar 24) to 14.66, marking a decrease of 0.28.
- For PBIT Margin (%), as of Mar 25, the value is 8.98. This value is below the healthy minimum of 10. It has decreased from 9.88 (Mar 24) to 8.98, marking a decrease of 0.90.
- For PBT Margin (%), as of Mar 25, the value is 8.24. This value is below the healthy minimum of 10. It has decreased from 9.24 (Mar 24) to 8.24, marking a decrease of 1.00.
- For Net Profit Margin (%), as of Mar 25, the value is 6.10. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.10, marking a decrease of 0.77.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 15. It has decreased from 10.01 (Mar 24) to 8.11, marking a decrease of 1.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.83. This value is within the healthy range. It has decreased from 13.12 (Mar 24) to 10.83, marking a decrease of 2.29.
- For Return On Assets (%), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 6.16, marking a decrease of 1.22.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.02. It has decreased from 1.12 (Mar 24) to 1.02, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 2.74. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 2.74, marking an increase of 0.34.
- For Quick Ratio (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.50, marking an increase of 0.25.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.82. This value is within the healthy range. It has increased from 1.99 (Mar 24) to 4.82, marking an increase of 2.83.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 43.84. This value is within the healthy range. It has increased from 31.04 (Mar 24) to 43.84, marking an increase of 12.80.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 22.71. This value is within the healthy range. It has increased from 17.88 (Mar 24) to 22.71, marking an increase of 4.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 56.16. This value is within the healthy range. It has decreased from 68.96 (Mar 24) to 56.16, marking a decrease of 12.80.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 77.29. This value exceeds the healthy maximum of 70. It has decreased from 82.12 (Mar 24) to 77.29, marking a decrease of 4.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 19.79. This value is within the healthy range. It has decreased from 23.30 (Mar 24) to 19.79, marking a decrease of 3.51.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 9.24, marking a decrease of 2.49.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,084.44. It has decreased from 20,231.08 (Mar 24) to 10,084.44, marking a decrease of 10,146.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has decreased from 6.94 (Mar 24) to 3.61, marking a decrease of 3.33.
- For EV / EBITDA (X), as of Mar 25, the value is 24.66. This value exceeds the healthy maximum of 15. It has decreased from 46.46 (Mar 24) to 24.66, marking a decrease of 21.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
- For Retention Ratios (%), as of Mar 25, the value is 56.15. This value is within the healthy range. It has decreased from 68.95 (Mar 24) to 56.15, marking a decrease of 12.80.
- For Price / BV (X), as of Mar 25, the value is 4.83. This value exceeds the healthy maximum of 3. It has decreased from 10.15 (Mar 24) to 4.83, marking a decrease of 5.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Relaxo Footwears Ltd:
- Net Profit Margin: 6.1%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.83% (Industry Average ROCE: 11.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.11% (Industry Average ROE: 8.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.24
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.5
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 62.3 (Industry average Stock P/E: 55.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.1%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Footwears | Aggarwal City Square, Plot No. 10, Manglam Place, Delhi Delhi 110085 | rfl@relaxofootwear.com http://www.relaxofootwear.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Kumar Dua | Chairman & Managing Director |
| Mr. Mukand Lal Dua | Whole Time Director |
| Mr. Nikhil Dua | Whole Time Director |
| Mr. Gaurav Dua | Whole Time Director |
| Mr. Sushil Batra | Executive Director |
| Mr. Kuldip Singh Dhingra | Independent Director |
| Mr. Rajeev Rupendra Bhadauria | Independent Director |
| Ms. Richa Arora | Independent Director |
| Mr. Yogesh Kapur | Independent Director |
| Mr. Raj Kumar Jain | Independent Director |
FAQ
What is the intrinsic value of Relaxo Footwears Ltd?
Relaxo Footwears Ltd's intrinsic value (as of 06 November 2025) is 351.55 which is 19.55% lower the current market price of 437.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 10,896 Cr. market cap, FY2025-2026 high/low of 782/375, reserves of ₹2,073 Cr, and liabilities of 2,762 Cr.
What is the Market Cap of Relaxo Footwears Ltd?
The Market Cap of Relaxo Footwears Ltd is 10,896 Cr..
What is the current Stock Price of Relaxo Footwears Ltd as on 06 November 2025?
The current stock price of Relaxo Footwears Ltd as on 06 November 2025 is 437.
What is the High / Low of Relaxo Footwears Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Relaxo Footwears Ltd stocks is 782/375.
What is the Stock P/E of Relaxo Footwears Ltd?
The Stock P/E of Relaxo Footwears Ltd is 62.3.
What is the Book Value of Relaxo Footwears Ltd?
The Book Value of Relaxo Footwears Ltd is 84.3.
What is the Dividend Yield of Relaxo Footwears Ltd?
The Dividend Yield of Relaxo Footwears Ltd is 0.69 %.
What is the ROCE of Relaxo Footwears Ltd?
The ROCE of Relaxo Footwears Ltd is 11.2 %.
What is the ROE of Relaxo Footwears Ltd?
The ROE of Relaxo Footwears Ltd is 8.31 %.
What is the Face Value of Relaxo Footwears Ltd?
The Face Value of Relaxo Footwears Ltd is 1.00.